未登录

M

Mahdi Habibi-Anbouhi

pasteur institute of iran

H指数:20

被引数:1,168

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Design and evaluation of an EpCAM-specific peptide–diphtheria toxin fusion (DT-SNFYMPL) for targeted epithelial cancer treatment

设计并评估一种EpCAM特异性肽-白喉毒素融合蛋白（DT-SNFYMPL）用于靶向上皮癌治疗

Medical Oncology

IF3.5

2026-07-220

PRE

Development of an ostrich-derived single-chain variable fragment (scFv) against PTPRN extracellular domain

SCIENTIFIC REPORTS

IF3.9

2024-02-142

OAAI

Site-specific transgene integration in chimeric antigen receptor (CAR) T cell therapies

BIOMARKER RESEARCH

IF11.5

2023-07-0417

OAAI

Production and characterization of a camelid single domain anti-CD22 antibody conjugated to DM1

MOLECULAR AND CELLULAR BIOCHEMISTRY

IF3.7

2023-05-026

PRE

Positive effect of acellular amniotic membrane dressing with immobilized growth factors in skin wound healing

JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A

IF3.9

2023-02-087

PRE

Selection and characterization of specific nanobody against neuropilin-1 for inhibition of angiogenesis

MOLECULAR IMMUNOLOGY

IF3

2020-12-0113

OAAI

Sustained release of TGF-1 via genetically-modified cells induces the chondrogenic differentiation of mesenchymal stem cells encapsulated in alginate sulfate hydrogels

JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE

IF4.5

2018-12-2914

PREAI

Tolerance induction by surface immobilization of Jagged-1 for immunoprotection of pancreatic islets

IF12.9

2018-11-0130

PREAI

Construction and evaluation of a whole-cell pneumococcal vaccine candidate

JOURNAL OF APPLIED MICROBIOLOGY

IF3.2

2018-09-271

PREAI

Efficacy of whole-cell pneumococcal vaccine in mice: A systematic review and meta-analysis

MICROBIAL PATHOGENESIS

IF3.5

2018-09-015

PREAI

Intrabody targeting vascular endothelial growth factor receptor-2 mediates downregulation of surface localization

CANCER GENE THERAPY

IF5

2016-12-1623

PREAI

Development of a recombinant camelid specific diabody against the heminecrolysin fraction of Hemiscorpius lepturus scorpion

IF2.4

2016-10-2425

OAAI

Epidermal growth factor receptor targeting alters gene expression and restores the adhesion function of cancerous cells as measured by single cell force spectroscopy

MOLECULAR AND CELLULAR BIOCHEMISTRY

IF3.7

2016-10-0112

PREAI

Soluble Expression and Characterization of a New scFv Directed to Human CD123

APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY

IF3.3

2016-01-098

PREAI

Inhibition of angiogenesis in human endothelial cell using VEGF specific nanobody

MOLECULAR IMMUNOLOGY

IF3

2015-05-0171

PREAI

Inducible VEGF Expression by Human Embryonic Stem Cell-Derived Mesenchymal Stromal Cells Reduces the Minimal Islet Mass Required to Reverse Diabetes

SCIENTIFIC REPORTS

IF3.9

2015-03-3045

OAAI

A camelid antibody candidate for development of a therapeutic agent against Hemiscorpius lepturus envenomation

IF4.2

2014-06-0226

OAAI

Immunological evaluation of predicted linear B-cell epitopes of human CD20 antigen

BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY

IF2.7

2012-03-273

PREAI

Generation and characterization of a functional Nanobody against the vascular endothelial growth factor receptor-2; angiogenesis cell receptor

MOLECULAR IMMUNOLOGY

IF3

2012-02-01105

PREAI